hvsa
Home
Courses
Course Objectives
Programs
CME Credits
Cases and Abstract Submissions
venue and accomodations
HVSA
Directors and Faculty
Videos
Register

 

New York City Conference

Back to 2014 Annual Meeting Abstracts


Mid-Term Follow-Up Of Haemodynamic Performance of the St. Jude Medical Trifecta Aortic Bioprosthesis in Young Patients Under 65
Amir Sepehripour, Jacob Chacko, Kulvinder Lall.
St Bartholomew's Hospital, London, United Kingdom.

OBJECTIVE: The St. Jude Medical Trifecta aortic supra-annular bioprosthesis is regarded as the next generation in pericardial stented tissue valves. The unique design of tissue leaflets attached to the exterior of the valve stent provides unrivalled in-vivo mean gradients and haemodynamics. The aim of this prospective study was to evaluate midterm haemodynamic performance of valve implanted into patients under 65.
METHODS: Twenty three consecutive patients undergoing aortic valve replacement using the St. Jude Medical Trifecta valve at a single UK centre over a 36-month period were included in this study. Patients undergoing concomitant cardiac procedures were included. All implanted valves were 19, 21, 23, 25 and 27mm in size. Assessment of haemodynamic function was carried out using transthoracic echocardiography pre-operatively and at follow-up, as well as transoesophageal echocardiography intra-operatively.
RESULTS: The study population consisted of 23 patients (12 male, 11 female). Mean age was 60.7±2.1 years. Implanted valve sizes were 19mm (n=3), 21mm (n=6), 23mm (n=7), 25mm (n=4) and 27mm (n=3). Overall mean post-operative pressure gradients were 7.34±4.2mmHg (mean) and 14.31±4.8mmHg (peak). Subgroup mean post-operative pressure gradients were 7.35±2.8mmHg, 7.62±2.1mmHg, 7.94±3.7mmHg, 7.61±2.7mmHg, 7.21±2.8mmHg, for the 19, 21, 23, 25 and 27mm cohort respectively. Overall mean post-operative left ventricular ejection fraction was 62±1.7%. Overall mean effective orifice area was 1.86±0.4cm2. There were only 2 patients with trivial regurgitation.
CONCLUSIONS: These results of our experience demonstrate excellent haemodynamic performance of the Trifecta bioprosthetic valve in young patients under 65.


Back to 2014 Annual Meeting Abstracts

     

Home | Courses | Objectives | Program | CME Credit | Cases & Abstracts | Venu & Accomodations | HVSA | Committee & Faculty | Register | Privacy Policy